Table 3.
Malignancy prediction improvement stratified by MIA3G for individual patient cohorts.
| Surgery | MIA3G IND | Malignancies* | Increase in malignancy prediction value | |
|---|---|---|---|---|
| Total | 207 | 39 | 19 | 431% |
| Based on symptoms | ||||
| Symptomatic | 131 | 26 | 12 | 404% |
| Asymptomatic | 76 | 13 | 7 | 485% |
| Based on menopausal status | ||||
| Premenopausal | 111 | 9 | 7 | 1,133% |
| Postmenopausal | 96 | 30 | 12 | 220% |
| Based on age group | ||||
| Age ≤ 55 | 139 | 18 | 14 | 672% |
| Age > 55 | 68 | 21 | 5 | 224% |
*Malignancies confirmed by surgical pathology studies.